NASDAQ · Drug Manufacturers - Specialty & Generic

SXTC (SXTC) Stock

$3.39 -7.01% NASDAQ: SXTC Healthcare

Valuation

MetricValue
Price$3.39
Market Cap$1.81M
P/E Ratio-0.20
P/B Ratio0.08
P/S Ratio1.36
EPS (TTM)$-8.18
52-Week High$1047.00
52-Week Low$0.06
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-20.00%
ROA-13.64%
ROCE-18.75%
Gross Margin-100.00%
Operating Margin-150.00%
Net Margin-2.74%
Debt/Equity0.06
Current Ratio3.50

Annual Financials (USD)

Metric20212022202320242025
Revenue$5.0M$3.0M$2.0M$2.0M$2.0M
Operating Profit$-2.0M$-5.0M$-6.0M$-3.0M$-3.0M
Net Profit$-3.0M$-6.0M$-6.0M$-3.0M$-3.0M
EPS$-95.48$-137.92$-22.23$-3.57$-8.18
Op Margin-46.0%-199.4%-284.4%-130.4%-154.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$35.0M$34.0M$30.0M$23.0M$22.0M
Total Liabilities$19.0M$17.0M$15.0M$9.0M$6.0M
Cash$13.0M$16.0M$17.0M$12.0M$18.0M
Borrowings$0$2.0M$4.0M$3.0M$1.0M

Latest News

China Sxt Pharmaceuticals Files Resale Registration for Up to 157.5 Million Shares MT Newswires · Jul 7, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-1.0M$0$0$-2.0M$-2.0M
Investing Cash Flow$-6.0M$0$0$0$0
Financing Cash Flow$13.0M$-1.0M$-3.0M$-4.0M$6.0M
Net Cash Flow$6.0M$2.0M$2.0M$-5.0M$6.0M
Free Cash Flow$-1.0M$0$0$-2.0M$-2.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-80.00%
Quick Ratio4.24
Interest Coverage-3.00
Return 1Y-98.97%
Return 3Y-99.65%
Return 5Y-99.97%

Ownership

Insiders Held109.48%
Institutions Held0.24%
Institutions Float Held-2.56%
Institutional HolderSharesReport Date
Sabby Management, LLC78,1702026-03-31
UBS Group AG12026-03-31
Caitong International Asset Management Co., Ltd12026-03-31
Royal Bank of Canada132026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPL $310.03 +1.45% 37.72 $4.55T 0.34%
MSFT $481.63 +0.27% 22.95 $3.58T 0.94%
GOOGL $344.20 +0.06% 27.68 $4.17T 0.23%
AMZNAmazon.com, Inc. $253.71 +1.00% 20.14 $2.73T 0.00%
META $543.67 -4.45% 21.47 $1.38T 0.35%

About SXTC

SXTC is led by CEO Feng Zhou, publicly traded since 2019.

SXTC stock trades at $3.39 with a market capitalization of $1.81M. The stock is valued at a price-to-earnings (P/E) ratio of -0.20, price-to-book of 0.08, price-to-sales of 1.36. Over the past 52 weeks the stock has ranged between $0.06 and $1047.00, and currently trades 99.7% below its 52-week high.

On profitability, SXTC generates a return on equity (ROE) of -20.00%, return on capital employed of -18.75%, an operating margin of -150.00%, a net profit margin of -2.74%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1226.67 +3.68% JNJ Drug Manufacturers - General $271.11 +3.33% ABBV Drug Manufacturers - General $258.92 +3.43% UNH Medical - Healthcare Plans $393.93 -0.43% MRK Drug Manufacturers - General $135.18 -0.58% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $589.04 +0.60% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $27.25 +1.41%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides